Area of research
Molecular Biology · Genetics
Research interest
Research interests include Epigenetics and DNA Methylation, Genetics and Neurodevelopmental Disorders, Chromatin Remodeling and Cancer, and Cancer Mechanisms and Therapy.
A neoantigen vaccine generates antitumour immunity in renal cell carcinoma
BBOX1 restrains TBK1-mTORC1 oncogenic signaling in clear cell renal cell carcinoma.
Spt6-Spn1 interaction is required for RNA polymerase II association and precise nucleosome positioning along transcribed genes
Loss of UBE3A impacts both neuronal and non-neuronal cells in human cerebral organoids.
SWI/SNF ATPase silenced HLF potentiates lung metastasis in solid cancers.
Activating NRF2<sup>E79Q</sup> mutation alters the differentiation of human non-small cell lung cancer.
Activating NRF2E79Q mutation alters the differentiation of human non-small cell lung cancer
2'3'-cGAMP interactome identifies 2'3'-cGAMP/Rab18/FosB signaling in cell migration control independent of innate immunity.
Septo-dentate gyrus cholinergic circuits modulate function and morphogenesis of adult neural stem cells through granule cell intermediaries.
Author Correction: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.
DAB2IP loss in luminal a breast cancer leads to NF-κB-associated aggressive oncogenic phenotypes.
Distinct roles for canonical and variant histone H3 lysine-36 in Polycomb silencing.
RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy.
RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy
RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy
RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy
Supplementary Table S1 from Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer
Data from Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer
Supplementary Table S1 from Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer
Data from Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer
Supplementary Data from Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer
Supplementary Data from Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer
Author Response: RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy
Data from PBRM1 Inactivation Promotes Upregulation of Human Endogenous Retroviruses in a HIF-Dependent Manner
Data from PBRM1 Inactivation Promotes Upregulation of Human Endogenous Retroviruses in a HIF-Dependent Manner
Supplementary Figure from PBRM1 Inactivation Promotes Upregulation of Human Endogenous Retroviruses in a HIF-Dependent Manner
Supplementary Figure from PBRM1 Inactivation Promotes Upregulation of Human Endogenous Retroviruses in a HIF-Dependent Manner
Supplementary Data from PBRM1 Inactivation Promotes Upregulation of Human Endogenous Retroviruses in a HIF-Dependent Manner
Supplementary Data from PBRM1 Inactivation Promotes Upregulation of Human Endogenous Retroviruses in a HIF-Dependent Manner
RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy